Peraquinsin

This classification denotes an antihypertensive agent with the molecular formula C23H28N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5726CF21KY, chemically known as 6,7-dimethoxy-2-(2-(4-(o-methoxyphenyl)-1-piperazinyl)ethyl)-4-(3h)-quinazolinone but generally known as peraquinsin, which bears US NIH Compound Identifier 3047831. European Medicines Agency schedules Peraquinsin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09714MIG. The term PERAQUINSIN is an International Non-Proprietary Name. PERAQUINSIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule peraquinsin under HS 29335995 and SITC 51576. As of Q4 2014, PERAQUINSIN remains the US FDA Preferred Term for this commodity. Peraquinsin bears US NLM identifiers UMLS ID C1882322 and NCI Concept Code C66351. SMILES: O(c1c(N2CCN(CC2)CCc2[nH]c3c(c(=O)n2)cc(OC)c(OC)c3)cccc1)C.